Unlocking New Hope: 2026 Projections and Key Drivers Fueling the Global Friedreich’s Ataxia Drug Market
For decades, patients diagnosed with Friedreich’s Ataxia (FA) faced a grim and agonizing reality: a progressive, life-shortening neurodegenerative disease with absolutely no approved disease-modifying treatments. Patients and their families were limited to symptomatic care and physical therapy as the genetic condition relentlessly stripped away muscle coordination, speech, and cardiac...
0 Yorumlar 0 hisse senetleri 57 Views 0 önizleme